"Infection risk with the use of interleukin inhibitors in hospitalized " by Thoyaja Koritala, Vishwanath Pattan et al.
Introduction: To date, only corticosteroids and inter-leukin-6 (IL-6) inhibitors have been shown to reduce mortality of hospitalized patients with COVID-19. In this literature review, we aimed to summarize infection risk of IL inhibitors, with or without the use of corticosteroids, used to treat hospitalized patients with COVID-19. Methods: A literature search was conducted using the following evidence-based medicine reviews: Cochrane Central Register of Controlled Trials; Cochrane Data-base of Systematic Reviews; Embase; Ovid Medline; and Epub Ahead of Print, In-Process, In-Data-Review & ...
Source: uow.edu.au